ARS-2, Low-Dose Intranasal Epinephrine, Improves Urticaria Scores in Patients with Frequent Urticaria Flares: Phase 2 Study ResultsDavid Bernstein, Neetu Talreja,Thomas Casale, H. Henry Li, Wayne Shreffler,Richard Lowenthal,Sarina TanimotoJournal of Allergy and Clinical Immunology（2024）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
